Literature DB >> 23084581

Chronic lymphocytic leukemia with t(14;18)(q32;q21).

Guilin Tang1, Haley E Banks, Rachel L Sargent, L Jeffrey Medeiros, Lynne V Abruzzo.   

Abstract

The t(14;18)(q32;q21) is a cytogenetic hallmark of follicular lymphoma and also occurs in approximately 20% of diffuse large B-cell lymphomas of follicle center cell origin. Relatively few cases of chronic lymphocytic leukemia/small lymphocytic lymphoma with t(14;18) have been reported previously. We report the clinicopathologic, cytogenetic, and molecular genetic features of 12 patients with chronic lymphocytic leukemia associated with t(14;18). There were 9 men and 3 women, with a median age of 51 years at diagnosis. To date, 11 patients have required chemotherapy, 6 before coming to our institution. At last follow-up, 5 patients have died of disease. Karyotypic analysis showed that 10 cases had t(14;18) in the stemline and 2 cases in the sideline; t(14;18) was the sole abnormality in the stemline in 2 cases. In 11 cases, other abnormalities were identified in the stemline or sidelines, most commonly trisomy 12 in 6 cases. Trisomy 12 was associated with atypical morphology and immunophenotype. Of 8 cases tested, 7 showed somatically mutated immunoglobulin heavy chain variable region genes. We conclude that the t(14;18) in chronic lymphocytic leukemia is associated with relatively young age at diagnosis, mutated immunoglobulin heavy chain variable region genes, and a clinical course that usually requires chemotherapy. The cytogenetic findings, in particular, t(14;18) in the stemline in 10 cases and as the sole karyotypic abnormality in 2 cases, suggest that t(14;18) is an early pathogenetic event in this small subset of chronic lymphocytic leukemia cases.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23084581      PMCID: PMC7147002          DOI: 10.1016/j.humpath.2012.07.005

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  33 in total

1.  Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).

Authors:  E J Moreau; E Matutes; R P A'Hern; A M Morilla; R M Morilla; K A Owusu-Ankomah; B K Seon; D Catovsky
Journal:  Am J Clin Pathol       Date:  1997-10       Impact factor: 2.493

2.  Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

Authors:  J J Yunis; M M Oken; M E Kaplan; K M Ensrud; R R Howe; A Theologides
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

3.  In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.

Authors:  Lucile Baseggio; Marie-Odile Geay; Sophie Gazzo; Françoise Berger; Alexandra Traverse-Glehen; Martine Ffrench; Sandrine Hayette; Evelyne Callet-Bauchu; Aurélie Verney; Dominique Morel; Laurent Jallades; Jean-Pierre Magaud; Gilles Salles; Pascale Felman
Journal:  Br J Haematol       Date:  2012-06-12       Impact factor: 6.998

4.  Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.

Authors:  G Juliusson; D G Oscier; M Fitchett; F M Ross; G Stockdill; M J Mackie; A C Parker; G L Castoldi; A Guneo; S Knuutila; E Elonen; G Gahrton
Journal:  N Engl J Med       Date:  1990-09-13       Impact factor: 91.245

5.  Chronic lymphocytic leukemia with t(14;18) and trisomy 12.

Authors:  Filiz Sen; Raymond Lai; Maher Albitar
Journal:  Arch Pathol Lab Med       Date:  2002-12       Impact factor: 5.534

6.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

7.  ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

Authors:  Marta Crespo; Francesc Bosch; Neus Villamor; Beatriz Bellosillo; Dolors Colomer; María Rozman; Silvia Marcé; Armando López-Guillermo; Elies Campo; Emili Montserrat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

8.  Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.

Authors:  Joan H Admirand; George Z Rassidakis; Lynne V Abruzzo; Jose R Valbuena; Dan Jones; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2004-08       Impact factor: 7.842

9.  Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.

Authors:  Francesco Cavazzini; Jose Angel Hernandez; Alessandro Gozzetti; Antonella Russo Rossi; Cristiano De Angeli; Ruana Tiseo; Antonella Bardi; Elisa Tammiso; Rosaria Crupi; Maria Pia Lenoci; Francesco Forconi; Francesco Lauria; Roberto Marasca; Rossana Maffei; Giuseppe Torelli; Marcos Gonzalez; Patricia Martin-Jimenez; Jesus Maria Hernandez; Gian Matteo Rigolin; Antonio Cuneo
Journal:  Br J Haematol       Date:  2008-06-28       Impact factor: 6.998

10.  Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients.

Authors:  E Matutes; D Oscier; J Garcia-Marco; J Ellis; A Copplestone; R Gillingham; T Hamblin; D Lens; G J Swansbury; D Catovsky
Journal:  Br J Haematol       Date:  1996-02       Impact factor: 6.998

View more
  9 in total

1.  The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia.

Authors:  Yan Li; Shimin Hu; Sa A Wang; Shaoying Li; Yang O Huh; Zhenya Tang; L Jeffrey Medeiros; Guilin Tang
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

2.  IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.

Authors:  Hong Fang; Kaaren K Reichard; Kari G Rabe; Curtis A Hanson; Timothy G Call; Wei Ding; Saad S Kenderian; Eli Muchtar; Susan M Schwager; Jose F Leis; Asher A Chanan-Khan; Susan L Slager; Esteban Braggio; Stephanie A Smoley; Neil E Kay; Tait D Shanafelt; Daniel L Van Dyke; Sameer A Parikh
Journal:  Am J Hematol       Date:  2019-01-08       Impact factor: 10.047

3.  LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemia.

Authors:  Wei Liu; Jan A Burger; Jie Xu; Zhenya Tang; Gokce Toruner; Mahsa Khanlari; L Jeffrey Medeiros; Guilin Tang
Journal:  Ann Hematol       Date:  2020-08-24       Impact factor: 3.673

4.  Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.

Authors:  Marc DE Braekeleer; Corine Tous; Nadia Guéganic; Marie-Josée LE Bris; Audrey Basinko; Frédéric Morel; Nathalie Douet-Guilbert
Journal:  Mol Clin Oncol       Date:  2016-02-26

5.  t(14;18)(q32;q21) in chronic lymphocytic leukemia patients: Report of two cases and a literature review.

Authors:  Weifeng Chen; Yi Miao; Rong Wang; Yujie Wu; Hairong Qiu; Wei Xu; Jianyong Li; Lei Fan; Xin Xu
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

Review 6.  The spectrum of chromosomal translocations in the Arab world: ethnic-specific chromosomal translocations and their relevance to diseases.

Authors:  Hadeel T Zedan; Fatma H Ali; Hatem Zayed
Journal:  Chromosoma       Date:  2022-07-30       Impact factor: 2.919

7.  Co-occurrence of JAK2 V617F-mutated essential thrombocythemia and chronic lymphocytic leukemia harboring der(8;17)(q10;q10).

Authors:  Masahiro Manabe; Nao Tanizawa; Satoru Nanno; Yuuji Hagiwara; Reiko Asada; Ki-Ryang Koh
Journal:  Cancer Rep (Hoboken)       Date:  2022-06-17

8.  An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinib.

Authors:  Fady Gh Haddad; Alain Chebly; Antoine El Sett; Hampig Raphael Kourie; Chantal Farra
Journal:  Leuk Res Rep       Date:  2021-05-11

9.  Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) As a Sole Cytogenetic Abnormality.

Authors:  Ghaleb Elyamany; Kamal Fadalla; Hatem Elghezal; Omar Alsuhaibani; Hani Osman; Abdulaziz Al-Abulaaly
Journal:  Clin Med Insights Pathol       Date:  2014-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.